Trials Sponsors Conditions Drugs Pricing

Conditions

Disease Related Malnutrition

Outcome Measures

Primary Outcomes (3)

Acceptability and palatability of an oral nutriitonal supplement.
To assess the acceptability of the oral nutritional supplement in patients requiring oral nutritional supplementation. On day 7 of the intervention period an acceptability and preference questionnaire will be completed by the patient in order to seek their opinion on the taste, smell, texture and overall liking of the new oral nutrition supplement. Questions will be rated on a 7 point Likert scale (Strongly Agree, Somewhat agree, Neutral, Somewhat Disagree, Disagree, Disagree Strongly) and will relate to taste, smell, texure and overall liking.
7 days
Gastro-intestinal Tolerance
To assess the GI tolerance of the oral nutritional supplement in patients with or at risk of disease related malnutrition. Monitoring includes recording the number of any GI complaints and consistency of bowel movements via a diary for the first 7 days. A standardised gastrointestinal (GI) tolerance questionnaire to capture perceived severity (none, mild, moderate or severe) of common gastrointestinal symptoms (diarrhoea, constipation, bloating, abdominal discomfort, vomiting and nausea) will be recorded on day 1 (based on the 2 preceding days) and for the first 7 days during the intervention. Information about bowel movements will also be collected using the Bristol Stool Chart© at the same time points.
7 days
Compliance
To assess the compliance of patients taking the Study product as prescribed. This is measured by daily completion of a compliance diary, comparing consumed amount versus prescribed amount.
7 days

Study Arms (1)

AYMES SWIFT

EXPERIMENTAL

Patients with or at risk of disease related malnutrition (DRM), who have been clinically identified as requiring nutritional supplementation will be prescribed the study product for a period of 7 days.

Dietary Supplement: AYMES SWIFT oral nutritional supplementDietary Supplement: AYMES SWIFT FIBREDietary Supplement: AYMES SWIFT PLANT

Interventions

AYMES SWIFT oral nutritional supplementDietary supplement

The study supplement is an oral nutritional supplement and food for special medical purposes.

Also known as: AYMES SWIFT Fibre

AYMES SWIFT

AYMES SWIFT FIBREDietary supplement

An oral nutritional supplement and food for special medical purposes.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Male or female
≥ 18 years of age

Sponsors & Collaborators

Aymes International Limited
Industrylead

Study Sites (1)

Preston Hill Surgery

Harrow, HA3 9SN, United Kingdom

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: OTHER
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 22, 2026

First Posted

March 5, 2026

Study Start

October 1, 2022

Actual (reported)

Primary Completion

December 31, 2025

Actual (reported)

Tolerance, Palatability and Acceptability Evaluation of an Oral Nutrition Supplement

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Outcome Measures

Primary Outcomes (3)

Study Arms (1)

AYMES SWIFT

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Study Completion

Conditions

Outcome Measures

Primary Outcomes (3)

Study Arms (1)

AYMES SWIFT

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations